Pulmonary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lymph nodes in dogs.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Pharmacy and Science

• Publication date

  1998-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1021/JS980060RPMID 9811507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intratracheal inhalation vs intratracheal instillation: differences in particle effects.

  1997cited by this paper
• Use of microfluidizer processing for preparation of pharmaceutical suspensions

  1996cited by this paper
• Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model.

  1996cited by this paper
• Twelve major cancers.

  1996cited by this paper
• A model of focal cancer in rabbit lymph nodes.

  1996cited by this paper
• Time-lapse quantitative computed tomography lymphography: assessing lymphatic function in vivo.

  1994cited by this paper
• Percutaneous computed tomography lymphography in the rabbit by subcutaneously injected nanoparticulates.

  1994cited by this paper
• Iodinated nanoparticles for indirect computed tomography lymphography of the craniocervical and thoracic lymph nodes in normal dogs.

  1994cited by this paper
• Manual for Staging of Cancer

  1992cited by this paper
• Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.

  1992cited by this paper
• Time course and distribution of tungsten-laden macrophages in the hilar lymph nodes of the dog lung after experimental instillation of calcium tungstate into the left apical bronchus.

  1990cited by this paper
• The role of macrophages in particle translocation from lungs to lymph nodes.

  1985cited by this paper
• Retention of monodisperse or polydisperse aluminosilicate particles inhaled by dogs, rats, and mice.

  1983cited by this paper

• Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics.

  2023cites this paper
• Review on a Novel Advancement in Dry Powder Inhaler

  2023cites this paper
• Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects.

  2023cites this paper
• Magnetic polyvinyl alcohol microspheres with self-regulating temperature hyperthermia and CT/MR imaging for arterial embolization

  2022cites this paper
• Role of Lipid Nanocarriers in Lymphatic Targeting: Promises and Safety Considerations

  2021cites this paper
• Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs: part one: the effect of size.

  2020cites this paper
• Inhaled nanoparticles-An updated review.

  2020cites this paper
• Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioliomyomatosis.

  2019cites this paper
• Appropriate selection of an aggregation inhibitor of fine particles used for inhalation prepared by emulsion solvent diffusion

  2017cites this paper
• Formulation and Evaluation of Paclitaxel-loaded Nanoemulsion for Pulmonary Administration

  2016cites this paper
• Drug Delivery to the Lymphatic System

  2016cites this paper
• Evaluation of Lung Toxicity of Biodegradable Nanoparticles

  2015cites this paper
• Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization.

  2015cites this paper
• Desenvolvimento de novo agente de contraste iodado para nano-sistemas para imageamento por raio-x

  2015cites this paper
• Nano-sized drug delivery systems for lymphatic delivery.

  2014cites this paper
• Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.

  2014cites this paper
• Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses.

  2014cites this paper
• Iodinated NanoClusters as an inhaled CT contrast agent for lung visualization

  2014cites this paper
• Lung toxicity of biodegradable nanoparticles.

  2014cites this paper
• Contrast agents for preclinical targeted X-ray imaging.

  2014cites this paper
• Advanced drug delivery to the lymphatic system: lipid-based nanoformulations

  2013cites this paper
• Functionalized nanomaterials: their use as contrast agents in bioimaging: mono- and multimodal approaches

  2013cites this paper
• Expansions of supramolecular chemistry: nanocrystals, pharmaceutical cocrystals, imaging, and decorated olefins

  2012cites this paper
• Iodinated photosensitizing chitosan: self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation.

  2012cites this paper
• Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives

  2011cites this paper
• Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer.

  2011cites this paper
• How to detect a dwarf: in vivo imaging of nanoparticles in the lung.

  2011cites this paper
• Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.

  2010cites this paper
• Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

  2010cites this paper
• Improvement in the bioavailability of poorly water-soluble drugs via pulmonary delivery of nanoparticles

  2009cites this paper
• Disease guided optimization of the respiratory delivery of microparticulate formulations

  2008cites this paper
• A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles.

  2008cites this paper
• Disease guided optimization of the respiratory delivery of microparticulate formulations.

  2008cites this paper
• Inhaled nanoparticles--a current review.

  2008cites this paper
• Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging.

  2007cites this paper
• The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects

  2007cites this paper
• Aerosols as Drug Carriers

  2006cites this paper
• Lymphatic uptake of lipid nanoparticles following endotracheal administration

  2006cites this paper
• Appareil et procede pour examiner un objet au moyen de rayons x a dispersion elastique et d'un produit de contraste

  2004cites this paper
• Computed Tomography Lymphography With Intrapulmonary Injection of Iopamidol for Sentinel Lymph Node Localization

  2004cites this paper
• Potential of Magnetic Resonance Lymphography With Intrapulmonary Injection of Gadopentetate Dimeglumine for Visualization of the Pulmonary Lymphatic Basin in Dogs: Preliminary Results

  2003cites this paper
• Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles

  2002influential citation
• Pulmonary drug delivery systems: recent developments and prospects.

  2002cites this paper
• Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.

  2001cites this paper
• Experimentelle und klinische Ansätze zur Lymphknotenbildgebung

  2001cites this paper
• [Experimental and clinical approaches to lymph node imaging].

  2001cites this paper
• CT imaging of intrathoracic lymph nodes in dogs with bronchoscopically administered iodinated nanoparticles.

  1999cites this paper